(Q50991026)

English

Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies.

scientific article published on 31 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies. (English)

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

bacterial endocarditis

1 reference

based on heuristic

inferred from title

Michael J Rybak

2

object named as

Michael J Rybak

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

3

object named as

Glenn W Kaatz

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

1

object named as

Warren E Rose

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

language of work or name

0 references

publication date

31 May 2007

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

60

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

2

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

334-340

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Development of daptomycin for gram-positive infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

In vivo pharmacodynamic activity of daptomycin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Evaluation of daptomycin activity against Staphylococcus aureus in an in vitro pharmacodynamic model under normal and simulated impaired renal function

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: Cure with prolonged/high-dose daptomycin without toxicity

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Effect of protein binding of daptomycin on MIC and antibacterial activity

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM170

21 January 2018

Identifiers

10.1093/JAC/DKM170

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/17540670

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50991026&oldid=1846303518"